Despite declining demand for Covid-19 vaccines, India's vaccine king Cyrus Poonawalla -- whose portfolio includes listed financial services firm Poonawalla Fincorp as well as privately held vaccine giant Serum Institute of India -- held onto his spot as the country's fourth richest person, though his net worth fell 7 per cent from a year ago to USD 22.6 billion.
